Glen Shear

Glen Shear

Founder Glenco Development Corporation

Glen Shear has 30 years’ experience in the financial services, investment banking, high-tech, real estate and the medical marijuana, and brings extensive experience regarding financial management and reporting, operations oversight and risk management. For the last 3.5 years, Mr. Shear has been CFO of Garden Remedies, Inc. one of 7 groups in Massachusetts allowed to cultivate, process and dispense medical marijuana.

Mr. Shear received an MBA from the University of Chicago, (Chicago, IL), and a BA from Brandeis

University (Waltham, MA), Summa Cum Laude and Phi Beta Kappa. His career began with a large publicly listed Canadian real estate company, Cadillac Fairview, and he then worked at Chase

Manhattan Bank, where he gained real estate and corporate banking experience. Mr. Shear was a

Principal of Ernst & Young, where he assumed a senior management role in the liquidation of Standard Trust, a major Canadian lender. He was also a Principal in Cole & Partners, a corporate finance and valuation firm in Toronto, advising owners and senior managers regarding strategic partnerships, acquisitions, dispositions, management buy-outs and public market options, and raised capital for technology-focused VC funds.

In the late 1990s, Mr. Shear became Executive Director of Canada’s leading investment bank, CIBC

World Markets. He was involved in over $3.2 billion of successful equity transactions, including initial public offerings, mergers and acquisitions, portfolio acquisitions and other advisory assignments. From 1999 to present, Mr. Shear has directed his own strategic advisory and investment firm, Glenco Development Corporation. He was co-founder and CFO of Israel Technology Acquisition Corp. – Israel’s first special purpose acquisition corporation – which raised $36 million through a NASDAQ listing, and merged with IXI Mobile. Mr. Shear was CFO of Glycominds, and raised pre-IPO funds for Redhill Biotechnology.

Mr. Shear has advised numerous private and public companies, and high-net worth investors in Canada, the US and Israel regarding financing, mergers and acquisitions and real estate acquisitions.